FDA Approves SimpleScreen CRC Blood Test for Colorectal Cancer Screening

The prothrombin time test, commonly known as PT or protime, is a blood test that measures how long it takes for blood to clot. This test evaluates the clotting ability of blood and is particularly useful in monitoring patients who take anticoagulant medications like warfarin. The test measures specific proteins called clotting factors that are produced by the liver and are essential for proper blood coagulation. When a blood vessel is injured, these clotting factors work together in a cascade to form a blood clot and stop bleeding.

The PT test is frequently ordered to investigate unexplained bleeding or bruising, to check liver function, to monitor anticoagulation therapy, or before surgery to ensure normal clotting ability. The results are often reported as an INR, or International Normalized Ratio, which standardizes the results across different laboratories. A normal PT value typically ranges from 11 to 13.5 seconds, while a normal INR is usually between 0.8 and 1.1 for people not taking blood thinners. For patients on warfarin therapy, the target INR is usually between 2.0 and 3.0, though this can vary depending on the condition being treated.

Elevated PT or INR values indicate that blood takes longer to clot than normal, which may suggest several conditions. These include liver disease, vitamin K deficiency, clotting factor deficiencies, or the effect of anticoagulant medications. Certain antibiotics and other medications can also affect PT results. Low PT values are less common but may occur with vitamin K supplementation or in conditions that increase clotting risk. It is important to note that some foods high in vitamin K, such as leafy green vegetables, can affect PT results in patients taking warfarin.

The test requires a blood sample, usually drawn from a vein in the arm. No special preparation is typically needed, though patients should inform their healthcare provider about all medications and supplements they are taking. For those on warfarin, regular PT monitoring is essential to ensure the medication dose is appropriate and to prevent complications from either excessive bleeding or inadequate anticoagulation. The frequency of testing varies based on individual circumstances but may be as often as weekly when starting therapy or adjusting doses.